Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

zentiva k.s. - metforminhydrochlorid - filmovertrukne tabletter - 50+850 mg

Den Europæiske Union - dansk - EMA (European Medicines Agency)

sun pharmaceutical industries europe b.v. - sitagliptin fumarate, metformin hydrochloride - diabetes mellitus, type 2 - narkotika anvendt i diabetes - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride sun is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride sun is indicated in combination with a sulphonylurea (i. - , trepersoners-kombinationsbehandling) som supplement til diæt og motion hos patienter, der ikke er tilstrækkeligt kontrolleret på deres maksimal tolereret dosis af metformin og et sulphonylurea. sitagliptin/metformin hydrochloride sun is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. sitagliptin/metformin hydrochloride sun is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

tiefenbacher gmbh - metforminhydrochlorid, vildagliptin - filmovertrukne tabletter - 50+1000 mg

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

pharmconsul s.r.o. - metforminhydrochlorid - filmovertrukne tabletter - 500 mg

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

medical valley invest ab - metforminhydrochlorid - filmovertrukne tabletter - 1000 mg

Den Europæiske Union - dansk - EMA (European Medicines Agency)

novartis europharm limited - vildagliptin, metformin-hydrochlorid - diabetes mellitus, type 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 og 5. 1 for tilgængelige data på forskellige kombinationer).

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

actavis group ptc ehf. - metforminhydrochlorid - filmovertrukne tabletter - 850 mg

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

aurobindo pharma (malta) limited - metforminhydrochlorid - filmovertrukne tabletter - 1000 mg

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

aurobindo pharma (malta) limited - metforminhydrochlorid - filmovertrukne tabletter - 850 mg

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

bluefish pharmaceuticals ab - metforminhydrochlorid - filmovertrukne tabletter - 1000 mg